What is Amnion Foundation?
Based in Winston-Salem, North Carolina, the Amnion Foundation operates as a specialized 501(c)3 entity dedicated to the advancement of biotechnology through high-fidelity cell analysis and biobanking services. The organization focuses on the isolation and provision of primary cells, such as HUVEC and placental stem cells, which are critical for developing accurate birth tissue and barrier models. By ensuring that these biological components retain their in-vivo-like functions, the foundation provides essential infrastructure for laboratories and researchers aiming to push the boundaries of regenerative medicine and developmental biology. Their market position is defined by a commitment to scientific rigor and the ethical utilization of birth-associated tissues for experimental research.
How much funding has Amnion Foundation raised?
Amnion Foundation has raised a total of $85K across 1 funding round:
Debt
$85K
Debt (2021): $85K with participation from PPP
Key Investors in Amnion Foundation
PPP
Public-Private Partnership
What's next for Amnion Foundation?
With the recent influx of capital, the Amnion Foundation is expected to accelerate its strategic initiatives aimed at broadening its cell repository and refining its isolation methodologies. The organization is likely to focus on scaling its operational capacity to meet the growing demand for high-quality, functional primary cells in the global research community. As it transitions through this growth phase, the foundation will likely prioritize the integration of advanced analytical technologies to maintain its competitive edge in the life sciences sector. Future developments will likely center on expanding collaborative partnerships with academic and commercial laboratories, further cementing its status as a cornerstone of modern biobanking and cellular research.
See full Amnion Foundation company page
